Tuesday, March 13, 2012 5:41:16 PM
I think it's reasonable. I think there is something bigger going on behind the scenes. I also share the opinion of others that the management isn't very happy penny players own millions of their shares, and may be purposely holding back information. Remember, this company destroyed their shareholders from the dollars last year. Obliterated them.
Yes, some smart ones bought back in the pennies, but many funds, etc that held got hosed by their decisions. I can't buy into the speculation they give a damn about shareholders. However, they must care about their own investment in the company and it's progress. Ergo, the share price eventually will reflect progress. Good material events will happen and they must be 8K'd or Fong is going to get visits from the SEC, lol.
The company is progressing, but I'm not sure who exactly they want along for the ride.
Yes, some smart ones bought back in the pennies, but many funds, etc that held got hosed by their decisions. I can't buy into the speculation they give a damn about shareholders. However, they must care about their own investment in the company and it's progress. Ergo, the share price eventually will reflect progress. Good material events will happen and they must be 8K'd or Fong is going to get visits from the SEC, lol.
The company is progressing, but I'm not sure who exactly they want along for the ride.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
